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Myxoma virus is a leporipoxvirus that causes a highly lethal virulent disease known as myxomatosis in the European
rabbit. An important aspect of myxoma virus pathogenesis is the ability of the virus to productively infect lymphocytes and
spread to secondary sites via lymphatic channels. We investigated the infection of the CD4/ T lymphoma cell line RL-5 with
myxoma virus and Shope fibroma virus, a related but benign leporipoxvirus, and observed that myxoma virus, but not Shope
fibroma virus, was able to productively infect RL-5 cells. We also discovered that infection of RL-5 cells with Shope fibroma
virus or attenuated myxoma virus mutants containing disruptions in either the T2 or the M11L gene resulted in the rapid
induction of DNA fragmentation, followed by morphological changes and loss in cell integrity characteristic of cell death
by apoptosis. Purified exogenous T2 protein was unable to prevent apoptosis, suggesting that T2 functions intracellularly.
Thus, myxoma virus T2, originally described as a secreted homologue of the tumor necrosis factor receptor, and M11L, a
novel transmembrane species with no known cellular homologue, function to extend virus host range for replication in rabbit
T lymphocytes through the inhibition of apoptosis in infected T lymphocytes. q 1996 Academic Press, Inc.
Programmed cell death, or apoptosis, functions not sumably through its ability to inhibit an interleukin-1b
converting enzyme-like activity (4, 13).only to regulate development and homeostasis in higher
organisms, but also serves as an effective antiviral mech- Myxoma virus is a leporipoxvirus and the causative
agent of a highly lethal, virulent disease in the Europeananism. Because premature death of infected cells can
potentially limit the production of progeny virus, it is not rabbit (Oryctolagus cuniculus) known as myxomatosis
(14). The ability to productively infect lymphocytes is ansurprising that evolution has endowed many viruses with
genes encoding proteins that protect cells against pro- important aspect of myxoma virus pathogenesis in terms
of both the disruption of normal lymphocyte function andgrammed cell death (1 –8). These viral anti-apoptosis
the spread of virus to secondary sites within infectedgenes have been shown to intersect the programmed
lymphocytes (reviewed in 15, 16). Shope fibroma viruscell death pathway at a variety of junctures (9), thereby
(SFV) is a closely related leporipoxvirus that, unlike myx-providing the virus with a selective advantage by allowing
oma virus, induces a benign self-limiting infection in O.for replication in a greater spectrum of cell types. Among
cuniculus and does not productively infect lymphocytesthe poxviruses several genes have been identified that
(15, 16). To evaluate this distinction in lymphotropismcan function to prevent or delay apoptosis in specific
between myxoma virus (strain Lausanne) and SFV (straincell types, including the host range genes CHOhr from
Kasza) we investigated the infection of T lymphocytescowpox virus (10) and E3L from vaccinia virus (11), which
using the rabbit CD4/ T cell lymphoma cell line RL-5. Inare required in order to prevent or delay cell death by
addition, we also investigated the infection of RL-5 cellsapoptosis and allow fully productive infection in Chinese
with attenuated myxoma viruses containing disruptionhamster ovary cells and primate fibroblasts, respectively.
mutations in the SERP1 (17), T2 (18), or M11L (19) openThe SPI-1 gene from rabbitpox virus has also been
reading frames (designated vMyx-SERP10, vMyx-T20,shown to function as a host range gene, possibly by
and vMyx-M11L0, respectively). Each of these open read-blocking premature death of infected pig fibroblast or
ing frames have been shown to encode important viru-human A549 epithelial cells during infection (12). As well,
lence factors for myxoma virus infection in rabbits (17–the SPI-2/crmA protein from cowpox virus has been
20). SERP1 encodes a secreted member of the serpinshown to block apoptosis in a variety of cell types, pre-
family of serine proteinase inhibitors (21), T2 encodes
a secreted member of the tumor necrosis factor (TNF)
receptor superfamily (18), and M11L encodes a novel1 To whom reprint requests should be addressed.
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shrinkage and plasma membrane blebbing. We mea-
sured DNA fragmentation in RL-5 cells at various times
postinfection by quantitating the terminal deoxynucleoti-
dyl transferase-mediated incorporation of fluorescein-12-
dUTP into DNA using flow cytometric analysis and fluo-
rescence microscopy, as described (22). In addition,
changes in cell morphology were monitored by analysis
of the light-scattering properties of the cells by flow cy-
tometry as well as by microscopic examination. Among
cells infected with vMyx-T20, vMyx-M11L0, and SFV, but
not among mock-infected cells or cells infected with myx-
oma virus or vMyx-SERP10 (data not shown), flow cyto-
metric analysis revealed a significant population of cellsFIG. 1. Measurement of RL-5 cell integrity by trypan blue exclusion
undergoing DNA fragmentation (Fig. 2). By 16 hr p.i., 35–during viral infection. RL-5 cells [obtained from the NIH AIDS Reference
Reagent Program and cultured in RPMI 1640 (Gibco BRL Life Technolo- 40% of cells infected with vMyx-T20, vMyx-M11L0, and
gies, Inc.) supplemented with 10% fetal bovine serum (FBS; Gibco BRL SFV contained highly fragmented DNA as measured by
Life Technologies, Inc.)] were either mock infected or adsorbed with flow cytometry (Fig. 2 and Table 1). The light-scatteringvMyxlac, vMyx-M11L0 (described in 19), vMyx-T20 (described in 18),
properties of the cells, shown as plots of side scatter vsor SFV (strain Kasza; obtained from the ATCC) at a multiplicity of infec-
forward scatter in Fig. 2, clearly indicated the emergencetion (m.o.i.) of 10 PFU/cell and then incubated in RPMI 1640 containing
10% FBS at 377. Uptake of trypan blue was quantitated at 3, 6, 12, and of a population of cells that were smaller in size, seen
24 hr postinfection by cell counting using a hemacytometer. Results as a shift to the left in the forward scatter profile, also
are expressed as percentage of viability, representing the percentage indicative of cells undergoing apoptosis. In contrast, nei-of cells excluding trypan blue.
ther mock-infected cells nor cells infected with the paren-
tal myxoma virus contained significant amounts of frag-
mented DNA or any significant population of cells withtype II transmembrane protein that functions to prevent
the infiltration of inflammatory cells into infected sites in altered cell morphology (Fig. 2). Microscopic examination
of infected cells, shown in Fig. 3, confirmed these obser-vivo (19, 20). No significant sequence homology between
M11L and any other known cellular protein sequence vations. Cells infected with vMyx-T20, vMyx-M11L0, and
SFV manifested membrane blebbing, cell shrinkage, andhas been found to date.
We first made the surprising observation that RL-5 the condensation and compartmentalization of nuclei
characteristic of apoptotic cells (Figs. 3E–3J), whereascells infected at a multiplicity of 10 plaque forming units
(PFU) per cell with SFV, vMyx-M11L0, or vMyx-T20 under- neither mock-infected nor myxoma virus-infected cells
had this appearance (Figs. 3A–3D).went a dramatic loss of cell integrity as determined by
trypan blue exclusion, such that by 24 hr postinfection DNA fragmentation in infected RL-5 cells was ob-
served very early during virus infection. As indicated in(p.i.) only 25–35% of infected cells were able to exclude
trypan blue (Fig. 1). In contrast, cells that were either Table 1, by 3 hr p.i., before viral DNA replication has
begun, significant nuclear DNA fragmentation was ob-mock infected or infected with the parental derivative of
strain Lausanne myxoma virus (vMyxlac) at the same served in cells infected with vMyx-T20, vMyx-M11L0, and
SFV. This early induction of DNA fragmentation was mostmultiplicity of infection continued to exclude trypan blue
over the same period (Fig. 1). No comparable loss in dramatic during infection with vMyx-T20 and SFV such
that by 6 hr p.i., more than 40% of the cells were undergo-cell integrity was noted in RL-5 cells infected with vMyx-
SERP10, or in nonlymphoid cell lines such as BGMK or ing extensive DNA fragmentation (Table 1). DNA frag-
mentation was significant but less extensive in cells in-RK-13 upon infection with any of these viruses (data not
shown). Therefore, the maintenance of RL-5 cell integrity fected with vMyx-M11L0 at this time (Table 1). At 10 hr p.i.
with vMyx-T20 or SFV, the proportion of cells containingduring myxoma virus infection appears to rely upon the
expression of both the T2 and the M11L open reading fragmented DNA was reproducibly less than that ob-
served at 6 hr postinfection (see Table 1), suggestingframes, since deletion of either from the virus resulted
in the loss of cell integrity. that at least some apoptotic cells observed at 6 hr postin-
fection have been physically lost as intact cells fromWe next sought to determine the basis for this appar-
ent distinction between RL-5 cells infected with SFV or the infected cell population by this time, and/or that the
induction of apoptosis did not occur synchronously dur-the T20 and M11L0 myxoma virus mutants and compara-
ble infection with the parental myxoma virus. In general, ing the course of the infection. By 16 hr approximately
40% of the cells infected with vMyx-T20, vMyx-M11L0, orcell death may occur by one of two mechanisms: necro-
sis or programmed cell death (apoptosis). Characteristic SFV contained extensively fragmented DNA which could
be readily visualized as nucleosomal ‘‘ladders’’ by agar-features of apoptosis include a rapid induction of nuclear
DNA condensation and fragmentation, as well as cell ose gel electrophoresis (data not shown). We conclude
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TABLE 1from these observations that infection of RL-5 cells with
vMyx-T20, vMyx-M11L0, and SFV, but not myxoma virus Quantitation of Apoptotic Cells during Viral Infection of RL-5 Cells
or vMyx-SERP10, resulted in the rapid induction of DNA
Percentage apoptotic cellsfragmentation and cell death by apoptosis.
HoursTo confirm that second site mutations are not respon-
postinfection Mock vMyxlac vMyx-M11L0 vMyx-T20 SFVsible for the apoptosis-inducing effects of vMyx-M11L0
and vMyx-T20, these viruses were reconstituted to wild 3 2 2 10 20 20
type by homologous recombination with plasmids con- 6 2 4 22 45 42
10 2 2 19 31 26taining myxoma wild-type sequences. vMyx-T20 was
16 4 6 38 41 37used in a cotransfection with pMyS2a (19), which con-
tains sequences surrounding the vMyxlac b-galactosi-
Note. RL-5 cells were mock infected or infected at a multiplicity of
dase insertion site, and pMTB5a (18), which contains the infection of 10 plaque forming units per cell and harvested at the indi-
intact T2 sequences. Foci negative for b-galactosidase cated times. The percentage of apoptotic cells was determined by
incorporation of fluorescein-12-dUTP by TdT as described in the legend
to Fig. 2. Numbers represent the percentage of positively staining cells
as determined by flow cytometric analysis.
were selected, and these were screened for virus, desig-
nated vMyx-T2-R, in which the T2 open reading frame
was reconstituted. Likewise, vMyx-M11L0 was used in
a transfection with pMyS2a which additionally contains
the intact M11L open reading frame. Virus, designated
vMyx-M11L-R, was selected, which was negative for b-
galactosidase and which has the M11L open reading
frame reconstituted. The extent of DNA fragmentation
induced in RL5 cells by vMyx-M11L-R or vMyx-T2-R was
identical to that induced by wild-type virus (data not
shown).
The myxoma virus T2 protein has been shown to bind
to and inhibit the cytocidal activity of rabbit TNF-a in vitro
(23). It was therefore possible that the T2 protein was
acting to inhibit the activity of extracellular TNF-a pro-
duced by RL-5 cells during myxoma virus infection. Two
observations suggest that this is not the case. First, data
provided in Table 2 show that the addition of exogenous,
purified myxoma virus T2 protein to the medium (5 mg/
ml) throughout infection of RL-5 cells with vMyx-T20 did
not rescue the cells from undergoing apoptosis. The con-
centration of T2 protein added to the medium in this
experiment was in excess of the amount of T2 secreted
into the medium during infection with wild-type myxoma
FIG. 2. Flow cytometric analysis of infected RL-5 cells demonstrating virus, and has been shown to be sufficient to inhibit the
virus-induced alteration in cell morphology and DNA fragmentation. cytocidal activity of rabbit TNF-a on L929 cells (M.S. and
Cells were either (A and B) mock infected or infected at an m.o.i. of
G.M., unpublished observations). It is therefore highly10 PFU/cell with (C and D) vMyxlac, (E and F) vMyx-M11L0, (G and H)
unlikely that the T2 protein could be functioning to protectvMyx-T20, or (I and J) SFV. At 16 hr postinfection cells were fixed for
30 min in 2% paraformaldehyde, permeabilized for 2 min on ice in 0.1% the cells from apoptotic cell death by binding to TNF-a
Triton X-100/0.1% sodium citrate, reacted with terminal deoxynucleoti- in the medium. Second, neither infected nor uninfected
dyl transferase (TdT; Boehringer Mannheim) and fluorescein-12-dUTP RL-5 cells are sensitive to cytolysis or induction of
(Boehringer Mannheim) (as described in 22) to stain fragmented DNA,
apoptosis by rabbit TNF-a (M.S. and G.M., unpublishedand subjected to flow cytometric analysis on a FACScan flow cytometer
observations). Therefore, we conclude that the T2 protein(Becton–Dickson, Mountain View, CA) equipped with an argon–ion
laser with 14 mW of excitation at 488 nm. Data were acquired on 104 must be synthesized de novo during myxoma virus infec-
cells/sample with light-scatter signals at linear gain and fluorescence tion in order to confer protection from apoptosis, that the
signals at logarithmic gain. Data are shown as plots of side scatter vs
T2 protein most likely exerts its anti-apoptotic effectsforward scatter (A, C, E, G, and I) and as histograms showing relative
from an intracellular location, and that the ability of thecell number vs log fluorescence intensity in arbitrary units (B, D, F, H,
and J). T2 protein to protect RL-5 cells from apoptosis is distinct
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FIG. 3. Microscopic examination of infected RL-5 cells. Cells were either (A and B) mock infected or infected at an m.o.i. of 10 PFU/cell with (C
and D) vMyxlac, (E and F) vMyx-M11L0, (G and H) vMyx-T20, or (I and J) SFV. At 16 hr postinfection cells were fixed, permeabilized, and reacted
with TdT and fluorescein-12-dUTP, as described in the legend to Fig. 2. Identical fields were photographed under fluorescence (A, C, E, G, and I)
or phase contrast (B, D, F, H, and J) microscopy, using a Zeiss Axioskop 20 fluorescence microscope equipped with a MC100 camera and TMAX
400 ASA film (Kodak).
from its previously described role as an extracellular in- Therefore, the induction of apoptosis in RL-5 cells func-
tions to limit the production of virus progeny. In addition,hibitor of TNF-a (23).
In order to determine whether the induction of since vMyx-SERP10 does not induce apoptosis in RL-5
cells (data not shown) and replicates to wild-type levelsapoptosis of RL-5 cells functions to limit the production
of progeny virus, we examined the growth of the different (Fig. 4), we conclude that reduced viral yields are not the
result of the Lac Z or Ecogpt genes, which are expressedviruses in RL-5 cells. As indicated in Fig. 4, the yield of
progeny virus from RL-5 cells infected with SFV, vMyx- from the recombinant viruses, and that the inability to
replicate in RL-5 cells is not a consequence of virusM11L0, or vMyx-T20 is significantly reduced in compari-
son to the parental myxoma virus or vMyx-SERP10. attenuation per se. In contrast, we observed no striking
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TABLE 2 oma virus T2 gene results in virus attenuation in infected
rabbits (18). The myxoma virus T2 protein is secretedQuantitation of Apoptotic Cells during Infection of RL-5 Cells
from infected cells early during infection and has beenin the Presence of Purified T2 Protein
shown to inhibit the cytocidal activity of rabbit TNF-a
Percentage apoptotic cells in vitro (23), presumably binding to TNF-a and thereby
precluding ligand–receptor interaction. Nevertheless,0T2 /T2
the results in this communication indicate that binding
and inhibition of soluble extracellular TNF-a cannot ex-Mock 2 2
vMyxlac 1 4 plain the requirement for T2 expression early during RL-
vMyx-T20 39 36 5 cell infection, since the addition of exogenous purified
T2 was unable to rescue vMyx-T20-infected cells from
Note. RL-5 cells were mock infected or infected at a multiplicity of
apoptosis. Although the intracellular distribution of theinfection of 10 PFU per cell in the presence or absence of purified T2
T2 protein has yet to be determined, these results sug-protein (5 mg/ml). Cells were harvested at 12 hr postinfection. The
percentage of apoptotic cells was determined by incorporation of fluo- gest that T2 may have other functions, in addition to
rescein-12-dUTP by TdT as described in the legend to Fig. 2. Numbers TNF-a binding, that require a cell-associated form of the
represent the percentage of positively staining cells as determined by protein.
flow cytometric analysis.
The observed requirement for expression of the M11L
protein in addition to T2 for productive RL-5 cell infection
by myxoma virus suggests that the inhibition of apoptosisdifferences in the production of viral progeny with any
of these viruses in RK-13 cells, which do not undergo during viral infection may involve components of more
than one cell death pathway. The M11L gene encodesapoptosis during infection (data not shown). Therefore
we conclude that viral growth is compromised by the a unique protein, predicted to be a type II transmembrane
protein, which is expressed early during infection (20).induction of apoptosis during infection of RL-5 cells and
that M11L and T2 can be formally classified as host With the exception of the predicted C10L protein en-
coded by swinepox virus (28) which shares 27% identityrange genes for the replication of myxoma virus in rabbit
T lymphocytes. with the M11L sequence, the M11L protein and its SFV
homologue share no significant homology with otherPrevious studies have indicated that myxoma virus is
able to productively infect primary cultures of rabbit known proteins and contain no motifs that allow predic-
tion of a biochemical function. Previous studies showedsplenocytes (19). In contrast, neither SFV nor vMyx-
M11L0 are able to replicate efficiently in unstimulated that the absence of M11L protein expression resulted in
marked attenuation of the virus in infected rabbits andprimary spleen cell cultures (19, 24). The results reported
here suggest that the observed defect in viral replication induced a disease syndrome characterized by extensive
inflammatory cell migration into infected sites (19, 20).in primary splenocytes may result from the rapid induc-
tion of apoptosis in rabbit lymphoid cells and that the Whether the extensive inflammation observed during in-
attenuated disease course in rabbits observed upon in-
fection with vMyx-M11L0 (19) or vMyx-T20 (18) may be
related to impaired virus replication in rabbit T lympho-
cytes. In addition, there is no simple correlation between
virus attenuation and failure to inhibit apoptosis in RL-5
cells, since vMyx-SERP10, which is comparably attenu-
ated in rabbits (17) does not induce apoptosis (data not
shown) and replicates to the same extent as the parental
myxoma virus (Fig. 4). Interestingly, infection of RL-5 cells
with SFV also resulted in a nonproductive infection char-
acterized by extensive cell death by apoptosis, even
though SFV encodes homologues of the myxoma virus
T2 and M11L proteins (25–27) that share 76 and 73%
amino acid identity, respectively, with their myxoma virus
FIG. 4. Replication of SFV, myxoma virus, and gene-disruption deriva-
counterparts. It is therefore entirely possible that there tives of myxoma virus in RL-5 cells. RL-5 cells were adsorbed with
are other genes, present in myxoma virus but functionally virus at a m.o.i. of 3 PFU/cell for 1 hr, washed to remove the inoculum,
and incubated at 377 at a cell density of 2–5 1 105 cells/ml in RPMIabsent from SFV, which are involved in blocking the apo-
1640 containing 10% FBS. Samples were harvested at 0, 24, 48, 72,ptotic response of RL-5 cells to leporipoxvirus infection.
and 96 hr postinfection. Virus titers were determined in duplicate onThe SFV and myxoma virus T2 genes encode secreted
BGMK cells as described (19). Data are expressed as total plaque
proteins that are homologous to the ligand-binding do- forming units produced at each time point. The viruses tested were
main of the receptors for the multifunctional cytokines SFV, vMyxlac (Myx), and myxoma virus derivatives with disruptions in
the SERP1 (Myx-SERP10), M11L (Myx-M11L0), and T2 (Myx-T20) genes.TNF-a/b (18, 26). Disruption of both copies of the myx-
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